DroneShield's Counter-Drone Momentum Meets a Wall of Short Sellers
Published on 08/11/2026 at 05:41 | Redaktion boerse-global.de
The Australian Securities Exchange has a new leader in its short-selling rankings, and it's a company that just can't seem to catch a break despite a steady stream of operational wins. DroneShield, the counter-drone technology specialist, closed Monday at EUR 1.33, down 2.71 percent on the day, after being flagged as the most shorted stock on the ASX — a distinction that underscores just how divided the market has become over the company's prospects.
That bearish positioning stands in stark contrast to the company's recent operational cadence. In the span of a few weeks, DroneShield has unveiled a new product, secured a US Air Force procurement process, and locked in fresh European military contracts worth AUD 23.2 million through its subsidiary COBBS BELUX BV. Yet none of it has been enough to convince a growing cohort of traders that the stock's downward trajectory is over.
The Gap Between Operations and Valuation
The numbers tell a sobering story for long-term holders. From its October 1 peak of EUR 3.79, the shares have shed roughly 64.86 percent of their value, with the decline accelerating after the company trimmed its revenue guidance. The stock now trades about 9.82 percent below its 50-day moving average of EUR 1.47, a technical signal that the near-term trend remains firmly negative.
What's particularly striking is that the operational news flow has been anything but quiet. On August 5, the US Air Force published a tender for DroneShield's IRK counter-drone detection systems at Goodfellow Air Force Base in Texas, with an award expected as early as September 1. A win there would further cement the company's footprint with US military customers and provide a tangible counterpoint to the pessimism embedded in the short interest.
Just days earlier, on July 31, the company announced those European defense contracts and laid out its full-year 2026 revenue guidance of AUD 250 million to AUD 270 million. First-half revenue is projected at AUD 125.8 million, including AUD 14.2 million in recurring revenue, with a gross margin of approximately 60 percent. The company also noted that AUD 206 million of the year's revenue is already secured through signed contracts.
Margin Concerns Trump Growth
The market's reaction to all this has been telling. Despite the contract wins and the growth trajectory, shares came under pressure on Friday — a move that analysts attributed to concerns over margin compression rather than any disappointment with the headline numbers. The first-half gross margin of 60 percent represents a notable step down from the 65 percent recorded in the prior-year period, a decline the company attributes to sales mix and currency effects.
That margin story has prompted a wave of analyst recalibration. Jefferies downgraded the stock to "Underperform" on August 5, cutting its price target to AUD 2.05, citing the weaker growth outlook. Bell Potter maintained its buy recommendation the same day but trimmed its target to AUD 2.50 following the interim results. The broader consensus estimate had already been slashed from AUD 2.05 to AUD 1.60 in late July, reflecting expectations of slower growth and thinner margins. An automated technical rating service has also issued a sell signal, forecasting further declines in the months ahead.
Institutional Crosscurrents
The share price action has been whipsawed by conflicting institutional signals. On August 4, news emerged that JPMorgan Chase had increased its voting rights stake in DroneShield, sending the stock higher and fueling a rally that extended over subsequent sessions. That optimism was short-lived. By Friday, reports surfaced that Citigroup-affiliated entities had taken a position of more than 5 percent in the company — a development that coincided with the latest leg down.
The juxtaposition of major financial institutions building positions while short sellers pile in has created an unusually volatile trading environment. On a weekly basis, the stock is still up 14.20 percent, largely thanks to the JPMorgan-driven bounce, but Monday's 2.93 percent decline suggests that the initial enthusiasm over institutional moves is being steadily eroded by guidance and margin concerns.
While institutional investors debate DroneShield's valuation, workplace safety leaders face a different kind of risk assessment — one where getting it wrong can mean fines, injuries, or worse. A free toolkit with 41 ready-to-use templates and checklists helps you document hazards properly and stay compliant with ease. Download the free Risk Assessment Toolkit
A Product Story in the Background
Amid the market drama, the company continues to push its technology forward. On Monday, DroneShield introduced RfRecon, a portable signals intelligence device built on its new RfAI-3 architecture, designed to detect, identify, and locate electromagnetic activity in tactical environments. The underlying RfAI-3 detection engine, first announced in late July, is intended to identify even previously unknown drone signatures.
The August 26 Verdict
All eyes now turn to August 26, when DroneShield will present its fully audited first-half results for 2026, accompanied by an investor conference. Until then, the stock appears destined to remain caught between the bears' conviction, the bulls' institutional firepower, and the promise of a potential US military contract award. With a market capitalization of approximately EUR 1.23 billion, DroneShield has become a battleground stock in every sense — one where the operational narrative and the market's risk appetite have yet to find common ground.
Just as DroneShield navigates volatile markets, UK employers face their own compliance challenges — especially around hazardous substances. A free COSHH toolkit with 43 customisable templates and toolbox talks helps you meet your legal duties for assessing dangerous substances, saving hours of paperwork. Get the free COSHH Toolkit
